ISSN: 2168-622X

Journal Home

JAMA Psychiatry Q1 Unclaimed

American Medical Association United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

JAMA Psychiatry is an international peer-reviewed journal for clinicians, scholars, and research scientists in psychiatry, mental health, behavioral science, and allied fields. The Archives of Neurology & Psychiatry began publication in 1919 and, in 1959, became 2 separate journals: Archives of Neurology and Archives of General Psychiatry. In 2013, their names changed to JAMA Neurology and JAMA Psychiatry, respectively. JAMA Psychiatry is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. It has an SJR impact factor of 6,578.

JAMA Psychiatry focuses its scope in these topics and keywords: health, alcohol, risk, depression, treatment, mental, bipolar, early, offspring, anxiety, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Psychiatry and Mental Health (Q1)

Price

4598 €

Inmediate OA

0 €

Embargoed OA

0 €

Non OA

Metrics

6,578

SJR Impact factor

394

H Index

212

Total Docs (Last Year)

699

Total Docs (3 years)

5673

Total Refs

7931

Total Cites (3 years)

382

Citable Docs (3 years)

11.48

Cites/Doc (2 years)

26.76

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1

Compare this journals

Aims and Scope

Best articles by citations

Brain Lactate as a Potential Biomarker for Comorbid Anxiety Disorder in Autism Spectrum Disorder

Brain Lactate as a Potential Biomarker for Comorbid Anxiety Disorder in Autism Spectrum Disorder - Reply

Association Between Lifetime Affective Symptoms and Premature Mortality

Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder

Assessment of the Role of IQ in Associations Between Population Density and Deprivation and Nonaffective Psychosis

Altered Markers of Cortical gamma-Aminobutyric Acid Neuronal Activity in Schizophrenia

Changes Over Time in the Differential Mortality Gap in Individuals With Mental Disorders

A Bayesian Observer Model of Drug Craving

Risk of Suicide Following Deliberate Self-poisoning

Association of Residential Mobility Over the Life Course With Nonaffective Psychosis in 1.4 Million Young People in Sweden

Relational Memory as a Possible Neurocognitive Marker of Schizophrenia

Sibling Comparisons and Confounding in Autism Epidemiological Studies

SHOW MORE ARTICLES

Sibling Comparisons and Confounding in Autism Epidemiological Studies - Reply

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations

Childhood Abuse and Military Experience - Important Information to Better Serve Those Who Have Served

Toward an Improved Understanding of Anhedonia

Retaining Part D's Comprehensive Coverage of Antidepressants

Negative Psychosis Prevention Trials

Anti-inflammatory Intervention in Depression

An Integrated Neuroscience Perspective on Formulation and Treatment Planning for Posttraumatic Stress Disorder

Anti-inflammatory Intervention in Depression - Reply

Depression Outcomes Associated With an Intervention Implemented in Employment Training Programs for Low-Income Adolescents and Young Adults

Adjunctive Intranasal Esketamine in Treatment-Resistant Depression

Public Safety, Mental Disorders, and Guns